Rapid production of interleukin-2-secreting tumor cells by herpes simplex virus-mediated gene transfer: Implications for autologous vaccine production

Human Gene Therapy

Volumn 7, Issue 18, 1996, Pages 2217-2224

  Tung, Cindy ^a   Federoff, Howard J ^b   Brownlee, Michael ^c   Karpoff, Howard ^a   Weigel, Tracey ^a   Brennan, Murray F ^a   Fong, Yuman ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; BETA GALACTOSIDASE; INTERLEUKIN 2; TUMOR VACCINE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE THERAPY; GENE TRANSFER; HEPATOBILIARY SYSTEM TUMOR; HEPATOMA CELL; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFRARED RADIATION; MOUSE; NONHUMAN; SPLEEN CELL; TUMOR IMMUNITY; VACCINE PRODUCTION; VIRUS REPLICATION;

ANIMALIA; ESCHERICHIA COLI; HERPES; MURINAE; SIMPLEXVIRUS;

EID: 0030450167     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.18-2217     Document Type: Article

References (28)

1. BERGOLD, P., CASSACCIA-BONNEFIL, P., XIU-LIU, Z., and FEDEROFF, H. (1993). Transsynaptic neuronal loss induced in hippocampal slice cultures by a herpes simplex virus vector expressing the GluR6 subunit of the kainate receptor. Proc. Natl. Acad. Sci. USA 90, 6165-6169.
2. BERGOLD, P.J., CASACCIA-BONNEFIL, P., XIU-LIU, Z., and FEDEROFF, H.J. (1993). Transsynaptic neuronal loss induced in hippocampal slice cultures by a herpes simplex virus vector expressing the GluR6 subunit of kainate receptor. Proc. Natl. Acad. Sci. USA 90, 6165-6169.
3. DANNENBERG, A.M., and SUGA, M. (1981). Histochemical stains for macrophages in cell smears and tissue sections: β-galactosidase, acid phophatase, nonspecific esterase, succinic dehydrogenase, and cytochrome oxidase. In Methods for Studying Mononuclear Phagocytes. D.O. Adams, P.J. Edelson, and M.S. Koren, eds. (Academic Press, New York) pp. 282-284.
4. DAVIDSON, B.L., ALLEN, E.D., KOZARSKY, K.F., WILSON, J.M. and ROESSLER, B.J. (1993). A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet. 3, 219-223.
5. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITTSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D., and MULLIGAN, R.C. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting immunity. Proc. Natl. Acad. Sci. USA 90, 3539-3543.
6. DRAZAN, K.E., SHEN, X.D., CSETE, M.E., ZHANG, W.W., ROTH, J.A., BUSUTTIL, R.W., and SHAKED, A. (1994). In vivo adenoviral-mediated human p53 tumor suppressor gene transfer and expression in rat liver after resection. Surgery 116, 197-204.
7. ENGVALL, E., PIHKO, H., JALANKO, H., and RUOSLAHTI, E. (1977). Effect of specific immunotherapy with preimmunization against alpha-fetoprotein on a mouse transplantable hepatoma. J. Natl. Cancer Inst. 59, 277-280.
8. FEDEROFF, H.J. (1996). Growth of replication defective herpes virus amplicon vectors and their use for gene transfer. In Cell Biology: A Laboratory Manual. D.L. Spector, L. Leinwand, and R. Goldman, eds. (Cold Spring Harbor Press, Cold Spring Harbor, NY).
9. GANSBACHER, B., ZIER, K., CRONIN, K., HANTZOPOULOS, P.A., BOUCHARD, B., HOUGHTON, A., GILBOA, E., and GOLDE, D. (1992). Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells. Blood 80, 2817-2825.
10. GELLER, A.I., and BREAKEFIELD, X.O. (1988). A defective HSV-1 vector expresses Escherichia coli β-galactosidase in cultured peripheral neurons. Science 241, 1667-1669.
11. GELLER, A.I., and FEDEROFF, H.J. (1991). The use of HSV-1 vectors to introduce heterologous genes into neurons: implications for gene therapy. In Human Gene Transfer. O. Cohen-Haguenauer and M. Botron, eds. (John Libbey Eurotext Ltd., London) pp. 63-73.
12. GESCHWIND, M., LU, B., and FEDEROFF, H.J. (1994). Expression of neurotrophic genes from herpes simplex virus type I vectors modifying neuronal phenotype. In Providing Pharmacological Access to the Brain: Alternative Approaches. T.R. Flanagan, D.F. Emerich, and S.R. Winn, eds. (Academic Press, New York) pp. 462-482.
13. JARNAGIN, W.R., DEBS, R.J., WANG, S.S., and BISSELL, D.M. (1992). Cationic lipid-mediated transfection of liver cells in primary culture. Nucleic Acids Res. 20, 4205-4211.
14. JOHNSON, P., MIYANOHARA, A., LEVINE, F., CAHILL, T., and FRIEDMANN, T. (1992). Cytotoxicity of a replication-defective mutant of herpes simplex virus type I. J. Virol. 66, 2952-2965.
15. LEIB, D.A., and OLIVO, P.D. (1993). Gene therapy to neurons: Is herpes simplex virus the right tool for the job? BioEssays 15, 547-554.
16. LINNIK, M., ZAHOS, P., GESCHWIND, M., and FEDEROFF, H. (1995). Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke 26, 1670-1675.
17. LOTZE, M.T., RUBIN, J.T., CARTY, S., EDINGTON, H., FERSON, P., LANDRENEAU, R., PIPPIN, B., POSNER, M., ROSENFELDER, D., WATSON, C., CARLOS, T., KIRKWOOD, J., LEMBERSKY, B., LOGAN, T., ROSENSTEIN, M., RYBACK, M.E., WHITESIDE, T., ELDER, E., MOEN, R.C., JACOB, W., CHEN, Y., PINKUS, R.L., and BRYANT, J. (1994). Clinical protocol: Gene therapy of cancer: a pilot study of IL-4-gene-modified fibroblasts admixed with autologous tumor to elicit an immune response. Hum. Gene Ther. 5, 41-55.
18. PAQUEREAU, L., and LE CAM, A. (1992). Electroporation-mediated gene transfer into hepatocytes: preservation of a growth hormone response. Anal. Biocheml 204, 147-151.
19. PATEL, P.M., FLEMMING, C.L., FISHER, C., PORTER, C.D., THOMAS, J.M., GORE, M.E., and COLLINS, M.K.L. (1994). Generation of interleukin-2-secreting melanoma cell populations from resected metastatic tumors. Hum. Gene Ther. 5, 577-584.
20. PATERSON, T., and EVERETT, R.A. (1990). A prominent serine-rich region in Vmw175, the major transcriptional regulator protein of herpes simplex virus type 1, is not essential for virus growth in tissue culture. J. Gen. Virol. 71, 1775-1783.
21. PORGADOR, A., BANNERJI, R., WATANABE, Y., FELDMAN, M., GILBOA, E., and EISENBACH, L. (1993). Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells. J. Immunol. 150, 1458-1470.
22. ROSENBERG, S.A., ANDERSON, W.F., BLAESE, M.R., ETTING-HAUSEN, S.E., HWU, P., KARP, S.E., KASID, A., MULE, J.J., PARKINSON, D.R., SALO, J.C., SCHWARTRUBER, D.J., TOPALIAN, S.L., WEBER, J.S., YANNELLI, J.R., YANG, J.C., and LINEHAN, W.M. (1992). Initial proposal of clinical research project: Immunization of cancer patients using autologous cancer cells modified by insertion of the gene for interleukin-2. Hum. Gene Ther. 3, 75-90.
23. SAITO, S., BANNERJI, R., GANSBACHER, B., ROSENTHAL, F.M., ROMANENKO, P., HESTON, W.D.W., FAIR, W.R., and GILBOA, E. (1994). Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines. Cancer Res. 54, 3516-3520.
24. SEIGLER, H.F., DARROW, T.L., ABDEL-WAHAB, Z., GANGAVALLI, R., and BARBER, J. (1994). Clinical protocol: A phase I trial of human gamma interferon transduced autologous tumor cells in patients with disseminated malignant melanoma. Hum. Gene Ther. 5, 761-777.
25. WILSON, J.M., JEFFERSON, D.M., CHOWDHURY, J.R., NOVIKOFF, P.M., JOHNSTON, D.E., and MULLIGAN, R.C. (1988). Retrovirus-mediated transduction of adult hepatocytes. Proc. Natl. Acad. Sci. USA 85, 3014-3018.
26. XU, H., FEDEROFF, H., MARAGOS, J., PARADA, L., and KESSLER, J. (1994). Viral transduction of trk A into cultured no-dose and spinal motor neurons conveys NGF responsiveness. Dev. Biol. 163, 152-161.
27. YANG, J., TSUKAMOTO, T., POPNIKOLOV, N., GUZMAN, R.C., CHEN, X., YANG, J.H., and NANDI, S. (1995). Adenoviral-mediated gene transfer into primary human and mouse mammary epithelial cells in vitro and in vivo. Cancer Lett. 98,s 9-17.
28. ZIER, K. (1982). Functional and antigenic properties of cultured T cells in the cell mediated lympholysis (CML) assay. Hum. Immunol. 4, 147-152.